A paper, made visible
Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.
- Available sources do not yet support a numeric visual.
What the available source describes
Study context is available. A quantitative result is not established here.
Study context 1 · source-backed descriptions
No supported numerical result is available for this comparison. No supported numeric visual is available.
Who or what was studied
adults at high risk for coronary disease
What was examined
combination therapy
high-dose statin monotherapy
Outcome named in the source
clinical outcomes
Inspect the source trail for this comparison
- Paper abstract ↗ · Abstractabstract · Matched to source text; not expert scientific review
Limited evidence suggests that combinations of lipid-lowering agents do not improve clinical outcomes more than high-dose statin monotherapy.
- Paper abstract ↗ · Abstractabstract · Matched to source text; not expert scientific review
PURPOSE: To compare the benefits and harms of high-dose statin monotherapy with those of combination therapy in adults at high risk for coronary disease.
Study context 2 · source-backed descriptions
No supported numerical result is available for this comparison. No supported numeric visual is available.
Who or what was studied
adults at high risk for coronary disease
What was examined
statin-ezetimibe treatment
Outcome named in the source
attainment of low-density lipoprotein cholesterol goals
Inspect the source trail for this comparison
- Paper abstract ↗ · Abstractabstract · Matched to source text; not expert scientific review
Very-low-quality evidence favors statin-ezetimibe treatment for attainment of low-density lipoprotein cholesterol goals.
- Paper abstract ↗ · Abstractabstract · Matched to source text; not expert scientific review
PURPOSE: To compare the benefits and harms of high-dose statin monotherapy with those of combination therapy in adults at high risk for coronary disease.
Study context 3 · source-backed descriptions
No supported numerical result is available for this comparison. No supported numeric visual is available.
Who or what was studied
adults at high risk for coronary disease
Inspect the source trail for this comparison
- Paper abstract ↗ · Abstractabstract · Matched to source text; not expert scientific review
Studies were generally short, focused on surrogate outcomes, and were heterogeneous in the sample's risk for coronary disease.
- Paper abstract ↗ · Abstractabstract · Matched to source text; not expert scientific review
PURPOSE: To compare the benefits and harms of high-dose statin monotherapy with those of combination therapy in adults at high risk for coronary disease.